0000902664-26-000556.txt : 20260129 0000902664-26-000556.hdr.sgml : 20260129 20260129112335 ACCESSION NUMBER: 0000902664-26-000556 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260129 DATE AS OF CHANGE: 20260129 EFFECTIVENESS DATE: 20260129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eagle Health Biopharma Long Only Onshore Fund LP CENTRAL INDEX KEY: 0002105065 ORGANIZATION NAME: EIN: 413171078 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-571583 FILM NUMBER: 26575895 BUSINESS ADDRESS: STREET 1: 3 GREENWICH OFFICE PARK STREET 2: 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06831 BUSINESS PHONE: 203-516-3750 MAIL ADDRESS: STREET 1: 3 GREENWICH OFFICE PARK STREET 2: 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06831 D 1 primary_doc.xml X0708 D LIVE 0002105065 Eagle Health Biopharma Long Only Onshore Fund LP 3 GREENWICH OFFICE PARK 3RD FLOOR GREENWICH CT CONNECTICUT 06831 203-516-3750 DELAWARE None None Limited Partnership true 2025 - Eagle Health Investments Fund GP LLC 3 Greenwich Office Park Suite 330 Greenwich CT CONNECTICUT 06831 Executive Officer General Partner Gary Stern c/o Eagle Health Investments LP 3 Greenwich Office Park, Suite 330 Greenwich CT CONNECTICUT 06831 Executive Officer Managing Partner - Eagle Health Investments LP 3 Greenwich Office Park Suite 330 Greenwich CT CONNECTICUT 06831 Promoter Investment Manager Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 false true true true false 0 Indefinite 0 Indefinite false 0 0 0 0 The Issuer charges a management fee that is described in the Issuer's offering documents. false Eagle Health Biopharma Long Only Onshore Fund LP /s/ Gary Stern Gary Stern Managing Partner 2026-01-28